Articles & guides — page 3

125 cited, vendor-independent pieces on the questions people actually ask — reconstitution and handling, half-lives, compound comparisons, and how to track a protocol. Research and education only; never dosing advice, never sourcing.

125 articles

Comparisons3 min

Retatrutide vs tirzepatide compared

Retatrutide and tirzepatide compared: the step from two receptors (GIP/GLP-1) to three (adding glucagon), and what retatrutide’s 2023 phase-2 obesity trial actually showed — up to ~24% weight loss.

Human clinical data
Comparisons3 min

Ipamorelin vs GHRP-6 vs GHRP-2

Three ghrelin-receptor (GHS) peptides compared in plain English: same class, same lever, but different "cleanliness" — why ipamorelin is called selective and GHRP-6/GHRP-2 carry side-signals.

Preclinical
Comparisons2 min

Tesamorelin vs CJC-1295

Two GHRH-analog peptides compared: tesamorelin and CJC-1295 pull the same lever, but one is an FDA-approved medicine with trial data and the other is a research compound. That gap is the real story.

Human clinical data
Half-life & pharmacology3 min

What is a half-life and why does it matter?

Half-life explained plainly: what it measures, the five-half-lives clearance rule, and why it decides how often a compound is dosed. Education only.

Concept / method
Half-life & pharmacology2 min

What is steady-state and drug accumulation?

Steady-state explained: how repeated doses accumulate until intake balances clearance, why it takes about five half-lives to reach, and what it means for level curves.

Concept / method
Half-life & pharmacology2 min

How long does semaglutide stay in your system?

How long semaglutide persists: with a ~7-day half-life, roughly five weeks to clear a single dose. The math, the accumulation caveat, and the cited sources.

Approved medicine
Half-life & pharmacology2 min

How long does tirzepatide stay in your system?

Tirzepatide persistence: a ~5-day half-life means roughly 25 days to clear a single dose, longer with accumulation. The math, the sources, and the caveats.

Approved medicine
Half-life & pharmacology2 min

What happens if you miss a semaglutide dose?

The pharmacology of a missed weekly semaglutide dose: why the ~7-day half-life cushions a late dose, and how far levels fall over time. Not medical advice.

Approved medicine
Half-life & pharmacology2 min

What happens if you miss a tirzepatide dose?

The kinetics of a missed weekly tirzepatide dose: how the ~5-day half-life shapes the decline in levels. Reference information, not medical advice.

Approved medicine
Half-life & pharmacology2 min

Why are GLP-1 medications dosed weekly?

The pharmacology behind weekly GLP-1 dosing: how a multi-day half-life, achieved by fatty-acid modification and albumin binding, makes once-weekly administration possible.

Approved medicine
Half-life & pharmacology2 min

BPC-157 half-life: why effects outlast the serum level

BPC-157's short serum half-life versus its longer-lasting effects in research — the pharmacokinetic-pharmacodynamic disconnect, explained with the primary PK data.

Preclinical
Half-life & pharmacology2 min

What does peptide concentration mean?

Concentration in mg/mL explained: why it is the bridge between vial size and syringe units, and why the same dose can be many different unit counts.

Concept / method

Zyra Track is a research and educational utility. Nothing on this page is medical advice, a dosing recommendation, or an endorsement of any compound. We never sell or source compounds and refuse sourcing questions. Consult a qualified clinician for decisions about your health.